A Sigma1R-dependent mechanism for modulatory activity of fenfluramine in restoring the architecture of dendritic arborization is an intriguing topic to be explored for possible disease-modifying activity in Dravet syndrome and other DEEs. Here, SIGMAR1 is linked to encephalopathy, progressive, early-onset, with brain edema and/or leukoencephalopathy.